Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Meredith

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|April 8, 2020
Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case ReportRifat Rahman, Leela Davies, Amir M Mohareb, et al.
Molecular and Cellular Biology|June 12, 2013
Program specificity for Ptf1a in pancreas versus neural tube development correlates with distinct collaborating cofactors and chromatin accessibilityDavid M Meredith, Mark D Borromeo, Tye G Deering, et al.
Neuro-Oncology Advances|January 4, 2021
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastomaTiffany G Baker, Jay Alden, Adrian M Dubuc, et al.
Nature Genetics|June 10, 2022
SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningiomaRoodolph St Pierre, Clayton K Collings, Daniel D Samé Guerra, et al.
American Journal of Clinical Pathology|August 15, 2025
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implicationsAli AlJabban, Roberta S Azevedo, Katherine Antel, et al.
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2024
Somatic Activating ESR1 Mutation in an Aggressive ProlactinomaTiciana Paes, Jacobo Buelvas Mebarak, John C Magnotto, et al.
JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2024
Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade GliomaSteven Tobochnik, Michael S Regan, Maria K C Dorotan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2023
ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult PatientsDavid M Meredith, Linda D Cooley, Adrian Dubuc, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|April 8, 2020
Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case ReportRifat Rahman, Leela Davies, Amir M Mohareb, et al.
Molecular and Cellular Biology|June 12, 2013
Program specificity for Ptf1a in pancreas versus neural tube development correlates with distinct collaborating cofactors and chromatin accessibilityDavid M Meredith, Mark D Borromeo, Tye G Deering, et al.
Neuro-Oncology Advances|January 4, 2021
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastomaTiffany G Baker, Jay Alden, Adrian M Dubuc, et al.
Nature Genetics|June 10, 2022
SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningiomaRoodolph St Pierre, Clayton K Collings, Daniel D Samé Guerra, et al.
American Journal of Clinical Pathology|August 15, 2025
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implicationsAli AlJabban, Roberta S Azevedo, Katherine Antel, et al.
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2024
Somatic Activating ESR1 Mutation in an Aggressive ProlactinomaTiciana Paes, Jacobo Buelvas Mebarak, John C Magnotto, et al.
JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2024
Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade GliomaSteven Tobochnik, Michael S Regan, Maria K C Dorotan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2023
ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult PatientsDavid M Meredith, Linda D Cooley, Adrian Dubuc, et al.
Pageof 7